Personalized Exercise for Cancer Survivors

This study is looking at how personalized exercise plans, delivered through a smartphone app called sFitRx and a fitness tracker, can help cancer survivors become more physically active and improve their health. You could be eligible if you are at least 18 years old, were diagnosed with stage 0-III cancer (like breast or lung cancer), and finished active cancer treatment at least three months ago (unless you are on maintenance immunotherapy or endocrine therapy). The study wants to see if using these tools helps people increase their physical activity levels over 6 and 12 months. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 160 participants. Participants will be divided into two groups: one receiving the sFitRx app and a fitness tracker, and another receiving only a Fitbit Inspire 3 fitness tracker.
What's involved
Physical activity will be measured at the start of the study, at six months, and again at 12 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months after the start of the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06840028

Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors

Active, Not Recruiting
NAAges 18+InterventionalPrevention
The University of Tennessee, Knoxville
~160 participants
Updated 2026-05-01 on ClinicalTrials.gov
What's tested:mHealth/sFitRxFitness Tracker

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Physical Activity
Measured over Baseline (i.e., pre-intervention), six months, and 12 months.
Cancer Survivors
Chronic Disease
Physical Activity
Cancer Survivorship
Physical Inactivity
Physical Activity in Adults
1 sites across 1 states
Tennessee1

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participant must be at least 18 years of age
Participant was previously diagnosed with stage 0-III cancer
Participant have had one or more of the cancers of interest (e.g., breast, lung)
Participant completed active cancer treatment at least three months prior to enrollment, with the exception of continued maintenance immunotherapy or endocrine therapy
Participant possess basic English communication capability
Participant do not participate in other health promotion programs
Participant is an Android or Apple smartphone owner
Participant is willing to participate in mHealth-delivered programs
Participant is willing to consent and be randomized
Participant has no contraindications to PA participation

Exclusion

Participant is currently undergoing chemotherapy or radiation as primary cancer treatment
Having any contraindications that might interfere with PA engagement, such as a medical condition and pacemaker implant
Plan to relocate or travel for \>two weeks during the study period;
Presence of distant metastasis
Planning or preparing for surgery as primary treatment or as a reconstruction procedure in the next 3 months
Have a stage 4 cancer diagnosis
Participant is already engaging in ≥75 min/week of vigorous-intensity PA, ≥150 min/week of moderate-intensity PA, or an equivalent combination of both over the last 3 months
An unstable mental condition that would prevent following study protocols
Reporting a Physical Activity Readiness Questionnaire (PAR-Q) score that indicates PA may be unsafe
Being a prisoner, pregnant, or planning to become pregnant
  • Physical ActivityBaseline (i.e., pre-intervention), six months, and 12 months.

    Physical Activity. CS's mean steps/day will be the primary outcome and will be assessed using Fitbit Inspire. Participants will be instructed to wear the Fitbit on the non-dominant wrist at all times throughout the study.